Prevalence of HIV-Related Stigma and its Impact on Status Disclosure among Adults on Antiretroviral Therapy in Abuja, Nigeria

  • Home
  • Prevalence of HIV-Related Stigma and its Impact on Status Disclosure among Adults on Antiretroviral Therapy in Abuja, Nigeria

Prevalence of HIV-Related Stigma and its Impact on Status Disclosure among Adults on Antiretroviral Therapy in Abuja, Nigeria

1Ogbu Arinzechukwu J.,2,3*Abubakar Imam,4Maimuna A. Abubakar,5Elizabeth O. Uloko,2,6Biyaya B. Nwankwo
1Aintree University Hospital, Lower Ln, Fazakerley, Liverpool L9 7AL, UK
2Department of Community Medicine, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria
3Department of Community Medicine, Federal University of Health Sciences, Azare, Bauchi State, Nigeria
4Department of Haematology, University of Abuja Teaching Hospital, Gwagwalada, Abuja,
Nigeria
5Heartland Hospital, Birmingham, UK
6Department of Community Medicine, University of Abuja, Abuja, Nigeria
ABSTRACT

Background: Despite significant advancements in Antiretroviral Therapy (ART), HIV-related stigma remains a critical barrier to effective treatment and prevention efforts. Non-disclosure of HIV status is a major consequence of this stigma, hindering social support, treatment adherence, and partner notification. This study aimed to determine the prevalence of HIV/AIDS-related stigma among adult patients receiving ART at the University of Abuja Teaching Hospital (UATH), Gwagwalada, and to assess the effect of this stigma on the disclosure of HIV status.
Methods: A descriptive cross-sectional study was conducted among adult patients receiving ART at UATH. A total of 290 respondents were recruited using a systematic sampling technique. Data were collected using a structured, validated questionnaire. Descriptive statistics were used to determine the prevalence of stigma. Chi-squared test and regression analyses were employed to examine the association between stigma and the likelihood of status disclosure.
Results: The mean age of respondents was 38.8 ± 11.3 years, with a majority being female (67.6%). The overall prevalence of stigma was 31.5%, while the prevalence of fear of stigma (perceived stigma) was 33.8%. Stigma was significantly associated with non-disclosure of HIV status. Specifically, the likelihood of non-disclosure was significantly higher among those who reported that disclosure is risky (a proxy for perceived stigma) compared to those who did not (p < 0.05). Furthermore, regression analysis showed that factors such as age, religion, occupation, and number of years since HIV positive were statistically significant predictors of personalized stigma (p < 0.05).
Conclusion: HIV-related stigma is highly prevalent among adult ART patients in Abuja and significantly impedes the disclosure of HIV status. These findings underscore the urgent need for targeted, facility-based and community-level anti-stigma interventions to improve disclosure rates, enhance social support, and ultimately strengthen the national HIV response.


KEYWORDS

HIV-related stigma, Status disclosure, Antiretroviral therapy (ART), Nigeria


REFERENCES

1) UNAIDS. (2023). Global HIV & AIDS statistics — 2023 fact sheet. [https://www.unaids.org/en/resources/fact-sheet]
2) Federal Ministry of Health Nigeria. (2020). Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018. [https://www.naiis.ng/]
3) UNAIDS. (2023). Country Factsheet: Nigeria. [https://www.unaids.org/en/regionscountries/countries/nigeria]
4) PEPFAR. (2022). PEPFAR Nigeria Country Operational Plan (COP) 2022. [https://www.state.gov/pepfar-nigeria-country-operational-plan-cop-2022/]
5) Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013). The end of AIDS: HIV infection as a chronic disease. The Lancet, 382(9903), 1525-1533. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61809-7/fulltext]
6) UNAIDS. (2025). 2025 Global AIDS Update. [https://www.unaids.org/sites/default/files/2025-07/2025-global-aids-update-JC3153_en.pdf]
7) Salihu, A. (2025). Scaling up access to antiretroviral treatment for HIV: lessons from Nigeria. Infectious Diseases of Poverty, 14(1), 1-10. [https://link.springer.com/article/10.1186/s12981-025-00711-1]
8) Parker, R., & Aggleton, P. (2003). HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Social Science & Medicine, 57(1), 13-24. [https://pubmed.ncbi.nlm.nih.gov/12753813/]
9) Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Prentice-Hall. [Placeholder: No direct URL, classic text]
10) Scambler, G. (2009). Health-related stigma.Sociology of Health & Illness, 31(3), 441-455. [https://onlinelibrary.wiley.com/doi/full/10.1111/j.1467-9566.2008.01124.x]
11) Rueda, S., et al. (2011). The impact of HIV-related stigma on psychological distress and quality of life in people living with HIV/AIDS: a systematic review and meta-analysis. Social Science & Medicine, 73(11), 1689-1699. [https://pubmed.ncbi.nlm.nih.gov/22018844/]
12) [Placeholder: Original reference 8]
13) Mann. J. Statement at an informal meeting on AIDS to the 42nd session of the UN General Assembly, October 20, 1987
14) Goffman E. Stigma: Notes on the Management of Spoiled Identity .New York; Simon and Shuster Inc.1963
15) Jones E, Farina A, Hastorf A, et al. Social Stigma: The psychology of Marked Relationships. New York. Freeman & Company, 1984
16) Simoni, J. M., et al. (2011). Social support and HIV-related stigma: a conceptual model and recommendations for research.AIDS and Behavior, 15(7), 1371-1380. [https://pubmed.ncbi.nlm.nih.gov/21710189/]
17) Kagee, A., & Remien, R. H. (2020). Social support and antiretroviral therapy adherence in people living with HIV: a systematic review and meta-analysis. AIDS Care, 32(10), 1215-1224. [https://pubmed.ncbi.nlm.nih.gov/32050800/]
18) Katz, I. T., et al. (2013). Impact of HIV-related stigma on treatment adherence: a systematic review and meta-synthesis. Journal of the International AIDS Society, 16(3), 1864.[https://onlinelibrary.wiley.com/doi/abs/10.7448/IAS.16.3.18640]
19) [Placeholder: Reference on disclosure and prevention]
20) Takwi, S. P., et al. (2025). A review of the impact of HIV status disclosure on mental health and adherence to antiretroviral therapy.BMC Public Health, 25(1), 1-10. [https://link.springer.com/article/10.1186/s12982-025-01229-7]
21) Jayaraman,KS. Indian State plans compulsory HIV testing, segregation and branding.NatureMedicine1998;4:378
22) Zierler S, Cunningham WE, Andersen R, Shapiro MF, Nakazono, TY, Morton S, et al. Violence victimization after HIV infection in a US probability sample of Adults patients in Primary care. Am J Public Health 2000; 90: 208- 215.
23) UNAIDS: HIV and AIDS-related Stigmatization, Discrimination and Denial: form, context and determinants (Research studies from Uganda and India); Best Practices Collection, UNAIDS 2000, accessed from www.unaids.org.
24) Gilmore, N, Somerville, MA. Stigmatization, Scapegoating and Discrimination in Sexually Transmitted Diseases: Overcoming “them” and “us”. Social Science and Medicine,1994;39:1339-1358.
25) Adeoye-Agboola, D. I., et al. (2016). Factors influencing HIV disclosure among people living with HIV/AIDS in Nigeria: a systematic review.Public Health, 134, 100-110. [https://www.sciencedirect.com/science/article/pii/S0033350616000780]
26) Msoka, P. C., et al. (2025). HIV status disclosure and related factors among children living with HIV in Tanzania. AIDS Care, 37(1), 1-8. [https://www.tandfonline.com/doi/full/10.1080/09540121.2025.2459301]
27) World Health Organization. Global Health Observatory Data. HIV/AIDS. www. who.int/gho/hiv/en. Accessed 28 Nov 2015.

 

Cite this article

Arinzechukwu J., O., Imam, A., Abubakar, M. A., Uloko, E. O., & Nwankwo, B. B. (2026). Prevalence of HIV-Related Stigma and its Impact on Status Disclosure among Adults on Antiretroviral Therapy in Abuja, Nigeria. INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH, 5(6), 548-554. https://doi.org/10.58806/ijhmr.2026.v5i6n05

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *